According to Aonong Biotech's announcement, the total shareholding ratio of Wu Youlin and his co-actors was 11.26% before the change, and 10.98% after the change. In June 2026, the company's restricted stock incentive plan was granted registration for the first time, passively diluting the shareholders' shareholding ratio. From June 14 to 15, 7.88 million shares of the company held by Wu Youlin were judicially auctioned, and the transfer was completed on July 27. This change does not violate promises, does not trigger an offer, does not cause changes in controlling shareholders, and does not affect the company's operations. There is uncertainty about the shareholders' shareholding situation in the future.

According to Aonong Biotech's announcement, the total shareholding ratio of Wu Youlin and his co-actors was 11.26% before the change, and 10.98% after the change. In June 2026, the company's restricted stock incentive plan was granted registration for the first time, passively diluting the shareholders' shareholding ratio. From June 14 to 15, 7.88 million shares of the company held by Wu Youlin were judicially auctioned, and the transfer was completed on July 27. This change does not violate promises, does not trigger an offer, does not cause changes in controlling shareholders, and does not affect the company's operations. There is uncertainty about the shareholders' shareholding situation in the future.